Muralidhara Ramachandra

This inventor holds 31 USPTO granted patents and 20 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Immunomodulation Compounds. Top assignees: Aurigene Discovery Technologies Limited, Aurigene Oncology Limited, Curis, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muralidhara Ramachandra. Retrieved from https://idiyas.com/inventor/muralidhara-ramachandra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 20)

% Patents Active = 67.7

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 5 (Patent Applications = 27)

Average Co-Inventor Count = 3.4

ph-index = 8

Forward Citations = 167(Granted Patents)

Company Filing History:

19 out of 45

Aurigene Discovery Technologies Limited

patents

10 out of 19

Aurigene Oncology Limited

Auirgene Discovery Technologies Limited

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Immunomodulators

1,2,4-Oxadiazole

CD47 Inhibitors

TIM-3 Pathway

PD-1 Pathway

Cyclic Peptidomimetics

Therapeutic Compounds

Immunosuppression

Small Molecule Inhibitors

Conjoint Therapies

Cancer Agents

Protease Inhibitors

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643870 - 1,2,4-oxadiazole derivatives as immunomodulators (2026-06-02),

2. 12565515 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signalling pathways (2026-03-03),

3. 12268670 - Combination of small molecule CD-47 inhibitors with other anti-cancer agents (2025-04-08),

4. 12226402 - Dual inhibitors of TIM-3 and PD-1 pathways (2025-02-18),

5. 12064418 - Conjoint therapies for immunomodulation (2024-08-20),

6. 12037321 - 1,2,4-oxadiazole derivatives as immunomodulators (2024-07-16),

7. 12005045 - Method of modulating TIGIT and PD-1 signalling pathways using 1,2,4-oxadiazole compounds (2024-06-11),

8. 11865114 - Method for treating diseases using SMARCA2/4 degraders (2024-01-09),

9. 11633394 - Substituted alkynylene compounds as anticancer agents (2023-04-25),

10. 11560403 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signaling pathways (2023-01-24),

11. 11512060 - 1,2,4-oxadiazole derivatives as immunomodulators (2022-11-29),

12. 11497735 - Conjoint therapies for immunomodulation (2022-11-15),

13. 11497734 - Dual inhibitors of TIM-3 and PD-1 pathways (2022-11-15),

14. 11465976 - 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators (2022-10-11),

15. 11311517 - Combination of small molecule CD-47 inhibitors with other anti-cancer agents (2022-04-26),

Title: The Innovative Journey of Muralidhara Ramachandra

Introduction: Muralidhara Ramachandra is a pioneering inventor based in Bengaluru, India, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Muralidhara Ramachandra holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his commitment to driving progress through innovation.

Career Highlights: With a career spanning over two decades, Muralidhara Ramachandra has worked with leading tech companies and research institutions, where he has spearheaded projects that have revolutionized the industry.

Collaborations: Throughout his career, Muralidhara Ramachandra has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion: Muralidhara Ramachandra's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the field of inventions. His work continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.